Andhra Pradesh - Rajahmundry   

‘Great future for tobacco in medicine’

Rajahmundry: Hari Senthidasan, Chief Operating Officer of Bitotech Elite Research and Innovations, Malaysia, has expressed confidence that his country will bring revolution in medicinal formulations of tobacco in the near future. He hoped India and Malaysia will sign a MoU on medicinal use and research in coming months. Senthidasan said that their main product Co-enzyme (Co-Q10) will be seen in Indian market after the said MoU as it has already captured markets in USA, Canada, Japan and other Asian countries.

The Malaysian representative along with Isamil Muzani Mohammad Yunus, Manager, Corporate Affairs, and assisted by Chief Scientist K. Mahendra were here in Central Tobacco Research Institute’s (CTRI) symposium on ‘Alternative uses of tobacco’ during 13th National Convention on Thursday. Mr. Hari said that Co-Q10 range of products, generally in capsule form are mostly used in anti-aging, weight loss, food and beverages, skin-care lotions, creams and other formulations. He explained that Coco-cola Company is also using Co-Q10 enzyme in their cola as an energy drink and their main motto and campaign is “Tobacco is not for cigarette making or smoking, it is a medicinal plant”. Bitotech Elite, as a company with alternative use of tobacco is aimed at 100 million turnover is taking part in Contract Farming in Malaysia. In coming months it is concentrate on many health supplements and nutrition foods which are made from tobacco extracts.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Restrict crop area, tobacco ryots told
‘Great future for tobacco in medicine’

Copyright © 2009, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu